Overview

An Open-label Trial of the Effect of Valacyclovir on Plasma HIV-1 Levels Among HIV-1 Seropositive and HSV-1/2 Seronegative Persons

Status:
Withdrawn

Trial end date:
2012-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to look at the effect of daily herpes medication, valacyclovir, on HIV levels in the blood in persons who are HIV positive and do not have oral or genital herpes.

Phase:

N/A

Details

Lead Sponsor:

University of Washington

Treatments:

Acyclovir
Valacyclovir